Summary
Protoporphyrinogen oxidase activity and ferrochelatase activity have been measured in blood lymphocytes from patients with porphyria variegata, and from some members of the family of one patient; the mean activity of protoporphyrinogen oxidase from patients was about 50% of that in lymphocytes from normal subjects; similar results were obtained from asymptomatic carriers in two generations of the patient's family. This finding confirms that a protoporphyrinogen oxidase decreased activity reflects the primary genetic defect in Porphyria Variegata. Data of ferrochelatase activity have been found usually in the normal range and these results are discussed.
Similar content being viewed by others
References
Becker DM, Viljoen JD, Katz J, Kramer S (1977) Reduced ferrochelatase activity: a defect common to porphyria variegata and protoporphyria. Br J Haematol 36:171–179
Bonkowsky HL, Bloomer JR, Ebert PS, Mahoney MJ (1975) Heme synthetase deficiency in human protoporphyria. J Clin Invest 56: 1139–1148
Bottomley SS (1968) Characterization and measurement of heme synthetase in normal human bone marrow. Blood 31:314–322
Boyum A (1968) Separation of leucocytes from blood and bone marrow. Scand J Clin Lab Invest 21: (Suppl) 97
Brenner DA, Bloomer JR (1980a) A fluorometric assay for measurement of protoporphyrinogen oxidase activity in mammalian tissue. Clin Chim Acta 100:259–769
Brenner DA, Bloomer JR (1980b) The enzymatic defect in variegate porphyria. New Engl J Med 302:765–769
Brodie MJ, Moore MR, Goldberg A (1977) Enzyme abnormalities in the porphyrias. Lancet 2:699–701
Elder GH, Evans JO, Thomas N, Cox R, Brodie MJ, Moore MR, Goldberg A, Nicholson DC (1976) The primary enzyme defect in hereditary coproporphyria. Lancet 2:1217–1219
Grandchamp B, Nordmann Y (1977) Decreased lymphocyte coproporphyrinogen oxidase activity in hereditary coproporphyria. Biochem Biophys Res Comm 74:1089–1095
Kushner JP, Barbuto AJ, Lee GR (1976) Am inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity. J Clin Invest 58:1089–1097
Lowry OH, Rosenbrough NH, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275
Mauzerall D, Granick S (1956) The occurrence and determination of delta aminolevulinic acid and porphobilinogen in urine. J Biol Chem 219:435–446
Meyer U, Schmid R (1978) The porphyrias: In: Stanbury J, Wyngaarden J, Fredrickson D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, p 1166
Pimstone NR, Blekkenhorst G, Eales L (1973) Enzymatic defects in hepatic porphyria. Enzyme 16:354–366
Schwartz S, Berg MH, Bossenmaier I, Dismore J (1960) Determination of porphyrins in biological materials. Methods Biochem Anal 8:221
Strand L, Felsher F, Redeker A, Marver HS (1970) Heme biosynthesis in intermittent acute porphyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity. Proc Natl Acad Sci USA 67:1315–1320
Viljoen DJ, Cayanis E, Becker DM, Kramer S, Dawson B, Bernstein R (1979) Reduced ferrochelatase activity in fibroblasts from patients with porphyria variegata. Am J Hemat 6:185–190
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Deybach, J.C., de Verneuil, H. & Nordmann, Y. The inherited enzymatic defect in porphyria variegata. Hum Genet 58, 425–428 (1981). https://doi.org/10.1007/BF00282829
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00282829